Consequently, CYP7A1 mutation in humans causes hypercholesterolemia, hypertriglyceridemia, and accumulation of cholesterol in the liver, despite induction of the alternative pathway [145]. This evidence concerns the gene CYP7A1 and Hypercholesterolemia.